Humanized Mouse Model Options for Autoimmune Diseases

December 7, 2021 Speaker: Steve Smith, PhD
Approximately 7% -9% of the global population suffers from autoimmune diseases. World-wide drug sales for the treatment of autoimmune diseases were about $55.2 billion in 2019 and are predicted to reach $152.2 billion by 2025. Better animal models can enable better and faster preclinical research and development into new potential treatments for autoimmune diseases.
In this webinar, we will share with you:
• Mechanisms of human autoimmunity
• Mouse models for the study of autoimmune diseases
• Evaluation of drug efficacy and safety in autoimmune diseases using humanized mouse models
For more information, please contact [e-mail]
#Neurodegenerativedisease #Alzheimersdisease #animalmodels #drugdevelopment #translationalmedicine #KOAP #knockoutallproject #CrisprCas9 #genomeediting #knockout #conditionalknockout #mousemodel #metabolicdisease #autoimmunedisease #oncology #CART #CARNK #immunotherapy #immunodeficient